Best Healthcare Research Agencies in Brazil
Compare top healthcare research agencies in Brazil for 2026. Find verified physician and patient panels to drive your life-sciences strategy and market access.
Quick answer
For large-scale clinical data and strategy, IQVIA; for specialized regional fieldwork and patient recruitment, Fine Research; for account-level commercial intelligence, BioNixus; and for broad, verified access to diverse healthcare professional and patient populations in Brazil, Global Vox Populi.
Selecting the right healthcare research agencies in Brazil requires balancing the demand for deep local clinical knowledge with the need for rigorous adherence to global data standards. The Brazilian market is defined by a dual-tier system where private insurance and public health providers operate under distinct regulatory frameworks, necessitating specialized research capabilities.
Decision-makers must weigh the benefits of large-scale, technology-integrated global firms against the agility of local specialists who provide nuanced access to hard-to-reach populations. This assessment provides a objective look at how different providers manage these challenges to support critical life-sciences and commercial decisions in 2026.
Best Healthcare Research Agencies in Brazil: rankings and scores
Exhibit 1: Ranking and weighted score (out of 100)
| Rank | Provider | Best for | Weighted score |
|---|---|---|---|
| 1 | IQVIA | Large-scale clinical and commercial strategy | 88.0 |
| 2 | Fine Brazil | Regional qualitative and quantitative fieldwork | 80.5 |
| 3 | Global Vox Populi | Verified healthcare professional and patient access | 78.0 |
| 4 | Escalent | Human-centric behavioral research | 75.0 |
| 5 | BioNixus | Account-level brand and commercial data | 74.5 |
| 6 | M3 Global Research | Rapid quantitative physician recruitment | 70.0 |
| 7 | 1•2•1 Insights Brazil | Marketing channel attribution and digital performance | 55.5 |
Exhibit 2: Provider comparison
| Provider | Audience types | Verification method | Certifications | Pricing model | Panel size and source | Minimum project |
|---|---|---|---|---|---|---|
| IQVIA | Pharma leadership, clinical researchers, pharmacy wholesalers | Internal data validation and site monitoring | Not stated on pages reviewed | Project quote | Not published | Not published |
| Fine Brazil | Healthcare professionals, patients, consumers | Standard industry fieldwork checks | Not stated on pages reviewed | Project quote | Not published | Not published |
| Global Vox Populi | Physicians, patients, nurses, payers, and providers | Multi-step validation against license and registry records | ISO 9001, ISO 20252, ISO/IEC 27001, HIPAA compliant; follows ESOMAR, Insights Association and BHBIA guidelines | Project quote | 100,600 healthcare professionals; 69,723 nurses and allied health professionals; 1,054,165 patient profiles (in Brazil; Global Vox Populi panel records, Oct 2026) | Not published |
| Escalent | Patients, physicians, healthcare decision-makers | Reliable group recruitment and data validation | Not stated on pages reviewed | Project quote | Not published | Not published |
| BioNixus | Physicians, payers, hospital decision-makers | Identity and quality checks on every wave | Not stated on pages reviewed | Project quote | Not published | Not published |
| M3 Global Research | Physicians, healthcare professionals | Proprietary panel verification protocols | Not stated on pages reviewed | Project quote | Not published | Not published |
| 1•2•1 Insights Brazil | Marketing leads, sales teams | Digital attribution and tracking logs | Not stated on pages reviewed | Subscription | Not published | Not published |
Exhibit 3: Capability matrix
| Provider | Quantitative | Qualitative | Own panels / sample | Healthcare | B2B | Multi-country |
|---|---|---|---|---|---|---|
| IQVIA | ● | – | – | ● | – | – |
| Fine Brazil | ● | ● | – | ● | ● | – |
| Global Vox Populi | ● | ● | ● | ● | ● | ● |
| Escalent | ● | ● | – | ● | – | – |
| BioNixus | ● | ● | – | ● | – | – |
| M3 Global Research | ● | ● | ● | ● | ● | ● |
| 1•2•1 Insights Brazil | ● | – | – | ● | ● | – |
Table data from each provider’s own website and public sources, reviewed October 2026. “Not published” means the provider does not state it publicly. ● highlighted in the provider’s own materials; – not highlighted (it may still offer it).
How we scored these providers
Select your research partner based on their proven ability to work through the specific regulatory and demographic complexities of the Brazilian healthcare system.
| Criterion | Weight | What it means here |
|---|---|---|
| Industry Expertise | 20 | This evaluates the depth of knowledge regarding the Brazilian healthcare system, including the distinction between private and public sectors. High-scoring agencies understand the regulatory pressures, clinician behaviors, and the specific needs of life-sciences firms operating within this complex, highly regulated market environment. |
| Compliance, Certifications and Security | 20 | Agencies must demonstrate adherence to ISO standards and local data protection laws. In healthcare, this includes solid protocols for adverse event reporting and the secure handling of sensitive patient information, which is a mandatory requirement for any credible research partner in the life-sciences sector. |
| Target Audience Reach | 15 | This measures the agency's ability to access specific, often hard-to-reach populations such as niche sub-specialists or rare-disease patients. Effectiveness is determined by the size and quality of proprietary panels and the granularity of profiling data available to make sure the right respondents are selected. |
| Research Quality | 10 | Quality is defined by the rigor applied to sampling, questionnaire design, and data validation processes. A reliable agency implements multi-layered checks to filter out fraudulent responses and make sure that the data collected is statistically meaningful and representative of the intended target group. |
| Market Presence | 10 | How established the provider is in this market: whether it appears repeatedly in what already ranks on Google for this search, and its size by headcount. Calculated by the script from the search record and company size, not judged by the writer. |
| Methodological Breadth | 10 | A strong agency offers a diverse toolkit, including qualitative techniques like IDIs and focus groups alongside quantitative online surveys and mobile-assisted data collection. This breadth allows for the selection of the most effective method based on the specific research objective and the target demographic's preferences. |
| Analytical Capability | 5 | Beyond data collection, the agency should provide meaningful interpretation that translates raw information into actionable business insights. This capability is measured by the ability to identify trends, segment audiences, and provide clear recommendations that directly address the client's core commercial or clinical questions. |
| Client Service and Speed | 5 | Responsiveness and project management efficiency are essential for maintaining tight timelines. High-scoring firms provide clear communication and proactive problem-solving, making sure that fieldwork runs smoothly and that any issues arising are addressed quickly without compromising the integrity of the research project. |
| Pricing and Feasibility Transparency | 5 | Providers should offer honest, up-front assessments of what is achievable, including realistic incidence rate expectations and timeline projections. Transparency regarding costs and potential risks allows for better budget management and prevents the disappointment of unmet expectations during the fieldwork phase. |
Why these weights. Healthcare and pharma research needs sector knowledge and strict compliance (adverse event reporting, HIPAA, health-data rules), so both lead with 20. Access to physicians, patients and payers follows (15), then design rigour and methods (10 each); analysis, service and pricing transparency (5 each) complete the score. Market presence (10) gives credit to providers that are established in this market: those that appear repeatedly in what already ranks for this search, and larger firms.
Each provider is scored 1 to 10 on every criterion from the evidence listed beside it (its own website and public sources, with the date reviewed). Weighted score = sum of score × weight ÷ 10, out of 100. Read the full scoring methodology. Global Vox Populi answers to ESOMAR’s 37 Questions for buyers of online samples show how Global Vox Populi recruits, verifies and protects its own panels.
Provider profiles: healthcare research agencies in Brazil
IQVIA: best for large-scale clinical and commercial strategy
Strongest fitGlobal pharmaceutical firms requiring massive data sets and end-to-end commercial strategy support.
IQVIA is a global entity with significant infrastructure in Brazil, focusing on the intersection of data, technology, and clinical expertise. They offer end-to-end support for pharmaceutical companies, ranging from clinical trial optimization to commercial strategy development.
Their model relies on massive, proprietary datasets and predictive modeling. In Brazil, they are a primary source for pharmacy sales data and real-world evidence, supporting high-level commercial decision-making for large life-sciences portfolios.
Scorecard: 88.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 10/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 9/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 8/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Research Quality | 10 | 9/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Market Presence | 10 | 10/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 9/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 7/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 6/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Weighted score | 100 | 88.0 |
Core services
- Clinical Development Solutions: Full-service clinical trial management and site identification using predictive models.
- Market Intelligence: Comprehensive data and analytics regarding pharmacy sales, market share, and payer dynamics.
- Commercial Strategy: Consulting and custom applications to optimize field force performance and patient adherence programs.
Strengths
- Data Scale: Access to petabytes of proprietary data and non-identified patient records to drive evidence generation.
- Technological Integration: Unified platforms like IQVIA.ai and Asset Maximizer connect data sources for faster decision-making.
Innovation and technology
- Agentic AI: Deploying AI-driven agents for field force optimization and global market insights.
Impact on businesses
- Risk Reduction: Accelerates clinical trials and commercial execution by connecting fragmented data sources.
Why it may fit your brief
IQVIA is ideal for high-budget, data-intensive projects. Smaller firms or those needing boutique, rapid-turnaround primary research may find more value elsewhere.
Fine Brazil: best for regional qualitative and quantitative fieldwork
Strongest fitInternational research agencies needing a reliable, on-the-ground partner for multi-country LATAM studies.
Fine Brazil operates as a dedicated fieldwork partner with a strong regional presence. They specialize in managing the operational complexities of data collection across Brazil, supporting international research agencies that require local expertise.
The agency maintains its own facilities and panels, emphasizing consistency across regional projects. Their team is trained in healthcare-specific methodologies and international standards, making them a preferred partner for global firms needing reliable execution in the Brazilian market.
Scorecard: 80.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 8/10 | fine-research.com (6 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 8/10 | fine-research.com (6 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 9/10 | fine-research.com (6 pages reviewed), Oct 2026 |
| Research Quality | 10 | 8/10 | fine-research.com (6 pages reviewed), Oct 2026 |
| Market Presence | 10 | 6/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 9/10 | fine-research.com (6 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 7/10 | fine-research.com (6 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 9/10 | fine-research.com (6 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 8/10 | fine-research.com (6 pages reviewed), Oct 2026 |
| Weighted score | 100 | 80.5 |
Core services
- Fieldwork Management: Execution of quantitative and qualitative fieldwork across Brazil and Latin America.
- Recruitment Services: Specialized recruitment of healthcare professionals and patients for research studies.
- Qualitative Facilities: Fully equipped facilities in central locations for focus groups and in-depth interviews.
Strengths
- Local Operational Scale: Regional infrastructure and owned operations across key markets in Brazil.
- Healthcare Specialization: Teams trained in healthcare methodologies and pharmacovigilance requirements.
Innovation and technology
- Regional Panel Management: Maintains one of the largest proprietary HCP panels in Latin America.
Impact on businesses
- Operational Consistency: Makes sure that global research requirements are adapted to local cultural and operational realities.
Why it may fit your brief
Fine Brazil is the right choice for firms wanting to outsource complex fieldwork to a specialist. It is less suited for clients seeking end-to-end strategic consulting.
Global Vox Populi: best for verified healthcare professional and patient access
- ISO 9001
- ISO 20252
- ISO/IEC 27001
- HIPAA compliant
Strongest fitGlobal research teams and pharmaceutical brand managers requiring high-integrity data for critical therapeutic market analysis.
Global Vox Populi functions as a primary research partner, providing direct access to proprietary panels in Brazil. The firm focuses on healthcare-specific fieldwork, using its own recruitment and validation infrastructure to support complex pharmaceutical and medical technology studies.
The agency’s presence in Brazil includes extensive panel coverage across medical specialties, nurses, and patient groups. It is positioned as a high-fidelity data collection source for international research teams requiring rigorous compliance and verified participant data.
Global Vox Populi panel coverage
All 12 proprietary panels together: 46,023,988 panellists across 199 markets, plus 71,411,997 patient profiles. Source: Global Vox Populi panel records, Oct 2026.
Healthcare professionals panel, in Brazil
100,600 panellists
- Primary & General42,230
- Internal Medicine Subspecialties8,438
- Acute, Peri-operative & Critical Care7,606
- Diagnostic & Laboratory6,968
- Women's & Reproductive Health6,848
- Surgical Specialties5,490
Nurses and allied health panel, in Brazil
69,723 panellists
- Registered Nurses24,111
- Advanced Practice Nurses1,528
- Licensed / Practical / Enrolled Nurses4,443
- Nursing Support (Aides / HCAs)2,600
- Midwives2,156
- Pharmacists & Pharmacy Techs5,140
Patient panel, in Brazil
1,054,165 patient profiles
- Aesthetics & Cosmetic346,987
- Cardiovascular73,778
- Endocrinology & Metabolic57,482
- Women's Health54,285
- Dermatology53,410
- Ophthalmology52,347
Across 731 conditions; a patient with more than one condition is counted once per condition.
Payers and providers panel, in Brazil
1,645 panellists
- Provider: Access & Administrative Roles1,053
- Payer: Access & Coverage Roles592
Scorecard: 78.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Compliance, Certifications and Security | 20 | 9/10 | ISO certificates and HIPAA policy, Oct 2026 |
| Target Audience Reach | 15 | 8/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Research Quality | 10 | 8/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Market Presence | 10 | 2/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Analytical Capability | 5 | 8/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Client Service and Speed | 5 | 8/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 8/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Weighted score | 100 | 78.0 |
Core services
- Healthcare Professional Research: Direct access to healthcare professionals with verified credentials across 70+ specialties.
- Patient and Caregiver Studies: Customized recruitment for patient populations across diverse therapeutic areas.
- Payer and Provider Insights: Primary data collection from payers and providers to inform market access strategy.
Strengths
- Proprietary Panel Depth: Maintains 100,600 HCPs and 1,054,165 patient profiles in Brazil, allowing for granular targeting.
- Verification Protocols: Clinical members are validated against licence records and re-validated on a rolling basis to protect data accuracy.
- Regulatory Compliance: Operates under ISO 9001, ISO 20252, and ISO/IEC 27001 standards with full HIPAA compliance for medical data.
Innovation and technology
- Advanced Quality Scoring: Uses device fingerprinting, trap questions, and speeding detection to remove fraudulent completes before delivery.
- Proprietary Hosting: Surveys are programmed and hosted on a dedicated platform, protecting full control over the research environment.
Impact on businesses
- Evidence-Based Decisions: Supports pharmaceutical and medtech clients in making informed choices regarding product launches and market access.
- Strategic Intelligence: Delivers actionable insights through solid sampling that reflects the real-world clinical environment in Brazil.
Why it may fit your brief
It is a strong fit for complex studies where respondent verification is the primary concern. For simpler, non-regulated consumer research, a generalist agency might be more cost-effective.
Escalent: best for human-centric behavioral research
Strongest fitCompanies needing a deep understanding of patient and physician behavior for brand positioning.
Escalent focuses on understanding the human behaviors that drive market disruption. They integrate behavioral science with data analytics to provide strategic advice for pharmaceutical and medical device manufacturers.
Their approach in Brazil involves conducting complex research programs, including patient journey mapping and brand strategy development. They use a mix of primary research and advanced data science to translate human behaviors into actionable insights for brands.
Scorecard: 75.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 8/10 | escalent.co (4 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 8/10 | escalent.co (4 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 8/10 | escalent.co (4 pages reviewed), Oct 2026 |
| Research Quality | 10 | 8/10 | escalent.co (4 pages reviewed), Oct 2026 |
| Market Presence | 10 | 4/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | escalent.co (4 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 8/10 | escalent.co (4 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 7/10 | escalent.co (4 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 7/10 | escalent.co (4 pages reviewed), Oct 2026 |
| Weighted score | 100 | 75.0 |
Core services
- Behavioral Research: Applying behavioral science principles to understand customer engagement and decision-making.
- Brand Strategy: Developing brand identities and positioning through deep market exploration.
- Data Sciences: Turning complex data sets into strategic insights using AI-enabled research tools.
Strengths
- Behavioral Expertise: Deep integration of behavioral science to uncover subconscious drivers of choice.
- Strategic Advisory: Combines research with consulting to help brands work through disruption.
Innovation and technology
- AI-Enabled Insights: Uses responsible AI to enhance human-led research and data analysis.
Impact on businesses
- Strategic Transformation: Translates complex human behaviors into ideas that impact brand growth.
Why it may fit your brief
Escalent is well-suited for high-level strategy and qualitative deep dives. For purely quantitative, rapid-turnaround data collection, other firms may be faster.
BioNixus: best for account-level brand and commercial data
Strongest fitMarketing and commercial teams needing to understand brand performance at the hospital or distributor level.
BioNixus provides primary research designed to fill the gaps left by traditional syndicated data feeds. They focus on granular, account-level performance metrics that help commercial and marketing teams make targeted decisions.
With a presence in Brazil, they execute studies that track brand performance at the hospital or department level. Their approach is designed to provide actionable decision packs that go beyond national averages, offering specific insights into traditional trade and sub-account dynamics.
Scorecard: 74.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 8/10 | bionixus.com (6 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 7/10 | bionixus.com (6 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 7/10 | bionixus.com (6 pages reviewed), Oct 2026 |
| Research Quality | 10 | 8/10 | bionixus.com (6 pages reviewed), Oct 2026 |
| Market Presence | 10 | 6/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | bionixus.com (6 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 9/10 | bionixus.com (6 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 8/10 | bionixus.com (6 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 7/10 | bionixus.com (6 pages reviewed), Oct 2026 |
| Weighted score | 100 | 74.5 |
Core services
- Account-Level Research: Primary research measuring brand versus competitor performance at the account and SKU level.
- Strategic Consulting: Market sizing, pricing and reimbursement, and KOL mapping to support launch readiness.
- Healthcare Primary Research: Statistically solid physician and payer surveys across hospital and private settings.
Strengths
- Granular Insights: Focuses on sub-accounts and traditional trade that syndicated subscriptions often miss.
- Actionable Outputs: Delivers decision packs designed for commercial and marketing directors rather than raw data exports.
Innovation and technology
- Rapid Scoping: Promises a project proposal within 48 hours of the client brief.
Impact on businesses
- Launch Optimization: Informs market access and launch plans with specific, local-level competitive intelligence.
Why it may fit your brief
BioNixus is excellent for tactical commercial questions. It may not be the best choice for large-scale, long-term patient journey tracking.
M3 Global Research: best for rapid quantitative physician recruitment
Strongest fitStudies requiring large-scale quantitative data from physicians with rapid turnaround times.
M3 Global Research is a fieldwork-focused agency known for its extensive proprietary panels of healthcare professionals. They provide rapid recruitment and data collection services, supporting global pharmaceutical companies in their research efforts.
Their operation in Brazil is centered on providing high-quality, verified physician samples for both quantitative and qualitative studies. They act as a core engine for international research firms needing consistent access to the medical community.
Scorecard: 70.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 7/10 | Search results and industry sources, Oct 2026 |
| Compliance, Certifications and Security | 20 | 7/10 | Search results and industry sources, Oct 2026 |
| Target Audience Reach | 15 | 9/10 | Search results and industry sources, Oct 2026 |
| Research Quality | 10 | 8/10 | Search results and industry sources, Oct 2026 |
| Market Presence | 10 | 3/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 7/10 | Search results and industry sources, Oct 2026 |
| Analytical Capability | 5 | 6/10 | Search results and industry sources, Oct 2026 |
| Client Service and Speed | 5 | 8/10 | Search results and industry sources, Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 7/10 | Search results and industry sources, Oct 2026 |
| Weighted score | 100 | 70.0 |
Core services
- Fieldwork Execution: High-quality data collection services for pharmaceutical and healthcare clients.
- Physician Recruitment: Rapid recruitment of specialists from a proprietary global panel.
- Data Collection: Managing both qualitative and quantitative research projects through verified channels.
Strengths
- Panel Scale: Maintains one of the world's largest proprietary panels of verified healthcare professionals.
- Execution Speed: Provides rapid recruitment capabilities for time-sensitive research projects.
Innovation and technology
- Verified Panel Infrastructure: Focuses on high-quality panel management to protect respondent accuracy.
Impact on businesses
- Research Efficiency: Enables global pharma companies to gather large-scale physician insights quickly.
Why it may fit your brief
M3 is ideal for quantitative volume. For complex, multi-methodological studies requiring strategic advisory, a firm like Escalent might be a better fit.
1•2•1 Insights Brazil: best for marketing channel attribution and digital performance
Strongest fitMarketing managers needing to track the ROI of digital ad spend and lead generation efforts.
1•2•1 Insights Brazil operates as a data-focused agency primarily centered on marketing performance. They provide a live dashboard that aggregates data from various digital channels to help businesses track lead generation and revenue conversion.
While they serve various industries, their focus is heavily on marketing analytics rather than clinical or medical-grade research. They are suited for clients looking to optimize digital ad spend and improve lead tracking metrics.
Scorecard: 55.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 5/10 | 121insights.com (1 page reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 5/10 | 121insights.com (1 page reviewed), Oct 2026 |
| Target Audience Reach | 15 | 5/10 | 121insights.com (1 page reviewed), Oct 2026 |
| Research Quality | 10 | 6/10 | 121insights.com (1 page reviewed), Oct 2026 |
| Market Presence | 10 | 6/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 6/10 | 121insights.com (1 page reviewed), Oct 2026 |
| Analytical Capability | 5 | 7/10 | 121insights.com (1 page reviewed), Oct 2026 |
| Client Service and Speed | 5 | 7/10 | 121insights.com (1 page reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 6/10 | 121insights.com (1 page reviewed), Oct 2026 |
| Weighted score | 100 | 55.5 |
Core services
- Marketing Analytics: Multi-touch attribution and ad performance tracking across Google and Meta.
- Lead Tracking: Mapping leads and revenue across geographic suburbs.
- Call Tracking: Recording and transcribing phone enquiries to attribute them to specific campaigns.
Strengths
- Live Dashboards: Refreshes marketing and sales data in real-time for immediate monitoring.
- Revenue-Linked Reporting: Ties marketing efforts to actual profit and sales goals.
Innovation and technology
- Heatmapping: Visualizes demand and lead conversion by postcode.
Impact on businesses
- Budget Optimization: Identifies underperforming ad sets to improve return on marketing spend.
Why it may fit your brief
This firm is suitable for marketing performance tracking. It is not designed for scientific healthcare research or clinical evidence generation.
How HCP and patient verification actually works in Brazil
Always demand documentation of the respondent verification process, specifically how the provider validates professional credentials against official medical registries.
Professional Credential Checks
Providers should cross-reference physician respondents against official Brazilian medical council registries or equivalent professional bodies. As a buyer, request a sample of the verification methodology. If the provider uses a third-party panel or an open-recruitment database, be wary of potential identity fraud. A high-quality agency will conduct this check during the recruitment phase and provide documentation that the panel members are indeed active, licensed practitioners in their stated specialty.
Identity Fingerprinting
Modern healthcare research requires technical safeguards beyond manual checks. Ask if the provider uses device fingerprinting, IP address verification, and geo-location tracking to make sure that the respondent is who they claim to be. This prevents duplicate entries and makes sure that participants are not using VPNs to mask their location. A transparent provider will detail these technical security layers in their project proposal, providing confidence in the integrity of the data collected.
Trap and Logic Questions
Reliable agencies incorporate attention-check or trap questions within the survey instrument to identify and remove respondents who are not paying sufficient attention. These questions help filter out bots and individuals who are rushing through the survey. If a provider cannot explain their strategy for identifying and removing these low-quality responses, the resulting insights may be unreliable. Always ask for the survey completion quality scoring criteria used to sanitize the final data set.
Rolling Re-validation
The best healthcare panels are not static. Ask if the agency conducts rolling re-validation of its panel members to protect their contact information, practice status, and specialty details remain current. A panel that is updated annually or on a per-project basis is far more trustworthy than one that has not been refreshed. This process is essential for maintaining the accuracy of data in a fast-moving medical market like Brazil.
How to choose the right provider in Brazil
Select your agency based on the specific research question, making sure that the provider's strengths in panel access or strategic advisory match your project needs.
- Define Research Objective: Distinguish between the need for raw, large-scale quantitative data and deep-dive qualitative insights. Choose a fieldwork specialist for the former and a strategic consultancy for the latter.
- Check Audience Access: Confirm the provider has direct, proprietary access to the specific medical sub-specialty or patient group you require. Avoid agencies that rely on rented, low-quality open-internet panels.
- Assess Local Knowledge: Make sure the agency understands the nuances of the Brazilian healthcare system, including the interaction between SUS and private insurance. This local expertise is essential for interpreting data correctly.
- Verify Compliance: Demand proof of ISO certifications and data protection policies. Make sure they have established protocols for reporting adverse events, which is mandatory for pharmaceutical research.
- Review Feasibility Reports: Require a realistic feasibility assessment that includes estimated incidence rates and recruitment timelines. Do not settle for vague promises of access without a clear plan.
Questions to ask before you commission
- How do you verify the credentials of the physicians in your panel against official Brazilian registries?
- Can you provide a feasibility report that includes the estimated incidence rate for my target population?
- What specific protocols do you have in place for reporting adverse events discovered during research?
- How do you protect data quality and filter out fraudulent or low-quality responses?
- Can you describe your experience with the private versus public healthcare divide in Brazil and how it impacts your sampling strategy?
Common pitfalls to avoid
- Over-relying on Syndicated Data: Assuming that national syndicated data provides enough depth for account-level commercial decisions is a common error that misses critical local market dynamics.
- Ignoring Verification Protocols: Failing to demand proof of respondent credentialing often leads to low-quality data and the inclusion of non-qualified participants in professional-only studies.
- Underestimating Regulatory Complexity: Treating healthcare research like consumer research ignores the mandatory compliance and adverse event reporting requirements essential in Brazil.
- Accepting Generic Feasibility: Agreeing to a project timeline without a detailed feasibility assessment often leads to significant delays when targeting niche or hard-to-reach medical specialists.
What a feasibility check should include
A rigorous feasibility check must account for the actual availability of the target sample rather than relying on theoretical panel totals.
Incidence Rate Analysis
A proper check must provide a realistic incidence rate based on historical data. This prevents unrealistic timelines when targeting rare conditions or specific hospital roles.
Sample Depth Assessment
The check should confirm the number of active, verified participants currently available in the specific Brazilian region needed. This avoids the risk of mid-project recruitment stalls.
Time-to-Complete Estimate
Protect the feasibility report outlines a clear, step-by-step recruitment schedule. This allows for accurate planning of the overall project duration.
Constraint Identification
The assessment should identify potential barriers, such as physician availability or regulatory restrictions, that could impact the speed or success of the fieldwork.
Conclusion
Choosing the right partner from the available healthcare research agencies in Brazil is a strategic decision that impacts the quality of your market intelligence. If you require large-scale commercial analytics and data-driven strategy, global firms like IQVIA provide the necessary infrastructure. For targeted fieldwork and deep access to specific medical populations, partners like Global Vox Populi or Fine Brazil offer the required proprietary panels and regional expertise.
Use the scorecard provided on this page to evaluate candidates against your specific project needs. Prioritize firms that demonstrate clear verification protocols and local regulatory knowledge. By matching the agency’s primary strengths to the specific demands of your brief, you protect the reliability of your findings and the success of your commercial or clinical initiatives in the Brazilian market.
Planning research in Brazil? Tell us your audience, markets and timeline, and we will come back with a feasibility check and recommended approach.
Frequently asked questions
What are the top healthcare market research agencies in Brazil?
The market includes global firms like IQVIA, which provides extensive data and strategy, and specialized fieldwork providers such as Fine Brazil and Global Vox Populi. BioNixus is also recognized for account-level commercial research. The 'best' agency depends on whether your need is for large-scale data analytics, qualitative patient insights, or rapid quantitative physician recruitment.
How do I find reliable healthcare fieldwork providers in Brazil?
Look for providers that own their own panels and can demonstrate a multi-step verification process for all respondents. Avoid agencies that rely on open-internet databases, as these often lack the necessary clinical credentialing. Ask for a project-specific feasibility report that details their actual recruitment capacity for your specific target population.
Does IQVIA operate healthcare research services in Brazil?
Yes, IQVIA has an extensive presence in Brazil with local offices and a large team. They provide a wide range of services including market intelligence, real-world evidence, pharmacy sales data, and commercial strategy support for pharmaceutical and life-sciences companies, helping them work through the complex local healthcare and regulatory environment.
What is the role of ANVISA in healthcare market research in Brazil?
ANVISA is the Brazilian Health Regulatory Agency. While it does not directly regulate market research, it sets the standards for drug and medical device approval. Research agencies must be aware of these standards, especially when conducting studies related to product claims, safety data, or the clinical environment, to make sure their work remains compliant with the broader health network.
Are there specialized AROs for clinical research in Brazil?
Yes, there are Academic Research Organizations (AROs) and Contract Research Organizations (CROs) active in Brazil. These firms specialize in clinical trial management and regulatory support. While distinct from market research agencies, they often collaborate with them to gather patient experience data or clinician feedback during the lifecycle of a clinical development program.
How does the Brazilian healthcare system (SUS vs private) affect market research?
Brazil operates a dual system: the public SUS and the private sector. Research strategies must account for these differences, as physicians, patients, and decision-makers in each system have different access to treatments, pricing structures, and clinical environments. A good research agency will tailor their sampling to reflect these distinct realities, as insights from one may not apply to the other.
What are the best practices for patient research under LGPD in Brazil?
Best practices include obtaining granular, revocable consent from all participants and making sure that data is de-identified or anonymized. Agencies should follow strict ISO/IEC 27001 standards for data security and maintain transparent records of data usage. LGPD compliance is mandatory, and agencies should clearly communicate how patient data is protected and used throughout the research process.
How can I protect the quality of physician data in Brazil?
Quality is protected by verifying professional licenses against official registries and using technical safeguards like device fingerprinting and trap questions. Avoid agencies that cannot explain their data sanitization process. The most reliable data comes from proprietary panels where participants are regularly re-validated and their professional credentials are confirmed before they are allowed to participate in any study.